Long-Term Liabilities: The sum of all non-current liabilities.
Intensity Therapeutics Inc. (INTS) had Long-Term Liabilities of $0.10M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.35M |
|
-- |
|
-- |
|
$3.39M |
|
$-3.39M |
|
$0.05M |
|
$-3.35M |
|
$-3.35M |
|
$-3.35M |
|
$-3.35M |
|
$-3.35M |
|
$-3.35M |
|
$-3.39M |
|
$-3.39M |
|
15.17M |
|
15.17M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$1.65M |
|
-- |
|
$1.41M |
|
$3.06M |
|
$2.63M |
|
$0.10M |
|
|
Long-Term Liabilities |
$0.10M |
$2.73M |
|
$0.33M |
|
$0.33M |
|
$0.33M |
|
15.27M |
|
| Cash Flow Statement Financials | |
$-1.99M |
|
$0.00M |
|
$0.33M |
|
$2.59M |
|
$0.93M |
|
$-1.66M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.63 |
|
-- |
|
-- |
|
0.23 |
|
0.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1002.10% |
|
-1002.10% |
|
-109.20% |
|
-767.66% |
|
$0.02 |
|
$-0.13 |
|
$-0.13 |
|